Dillon M. Voss

ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth

Wai Kit, Dillon M. Voss, Juergen Scharner et al. · Cancer Research · 2021 · 108 citations · Full text

Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression

Dillon M. Voss, Raffaella Spina, David L. Carter et al. · Scientific Reports · 2017 · 53 citations · Full text

Hypoxic Response, Chemoprevention Strategy, Tumor Progression +20

Exon-skipping antisense oligonucleotides for cystic fibrosis therapy

Young Jin Kim, Nicole Sivetz, Jessica Layne et al. · Proceedings of the National Academy of Sciences · 2022 · 37 citations · Full text

The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness

Dillon M. Voss, Anthony Sloan, Raffaella Spina et al. · Cancer Research · 2020 · 31 citations · Full text

Hypoxia-induced Stemness, Mbnl1 Activity, Cancer Biology +19

Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells

Raffaella Spina, Dillon M. Voss, Laura Asnaghi et al. · Oncotarget · 2015 · 26 citations · Full text